82 FR 58206 - National Health and Nutrition Examination Survey (NHANES) Stored Biologic Samples; Proposed Cost Schedule and Guidelines for Proposals to Use Serum, Plasma, and Urine Samples
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 82, Issue 236 (December 11, 2017)
Centers for Disease Control and Prevention
Federal Register Volume 82, Issue 236 (December 11, 2017)
| Page Range | 58206-58209 | |
| FR Document | 2017-26591 |
[Federal Register Volume 82, Number 236 (Monday, December 11, 2017)] [Notices] [Pages 58206-58209] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-26591] [[Page 58206]] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC-2017-0117] National Health and Nutrition Examination Survey (NHANES) Stored Biologic Samples; Proposed Cost Schedule and Guidelines for Proposals to Use Serum, Plasma, and Urine Samples AGENCY: Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HHS) announces the availability of stored sera, plasma, and urine samples obtained from participants in the National Health and Nutrition Examination Survey (NHANES) for use and the fee schedule for such use. The National Health and Nutrition Examination Survey (NHANES) is one of a series of health- related surveys conducted by CDC's National Center for Health Statistics (NCHS). DATES: The stored NHANES biologic samples are available December 11, 2017. The fee structure for these samples is effective December 11, 2017. FOR FURTHER INFORMATION CONTACT: Dr. Geraldine McQuillan, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Hyattsville, MD 20782. Telephone: 301- 458-4371; Fax: 301-458-4029; Email: [email protected]v Authority: Sections 301,306 and 308 of the Public Health Service Act (42 U.S.C. 241,242k and 242M). SUPPLEMENTARY INFORMATION: NHANES is a program of periodic surveys conducted by NCHS. Examination surveys conducted since 1960 by NCHS have provided national estimates of the health and nutritional status of the U.S. civilian non-institutionalized population. The goals of NHANES are: (1) To estimate the number and percent of persons in the U.S. population and designated subgroups with selected diseases and risk factors; (2) to monitor trends in the prevalence, awareness, treatment and control of selected diseases; (3) to monitor trends in risk behaviors and environmental exposures; (4) to analyze risk factors for selected diseases; (5) to study the relationship between diet, nutrition and health; (6) to explore emerging public health issues and new technologies; and (7) to establish and maintain a national probability sample of baseline information on health and nutrition status. Samples are available from NHANES III and the continuous NHANES that started in 1999. Approximately 30,000 individuals were examined in NHANES III, which began in the fall of 1988, and ended in the fall of 1994. Researchers can analyze data from this survey in two phases. Phase 1 was conducted from October 1988 to October 1991 and Phase 2 began October 1991 and ended October 1994. Though participants consented to storing samples of their blood and urine for future testing, only research proposals with test results that are judged not to have clinical significance for participants will be accepted. See: http://www.cdc.gov/nchs/nhanes/nhanes3.htm, for more information on NHANES III. Beginning in 1999, NHANES became a continuous, annual survey with examination of approximately 5,000 individuals a year and data release every two years. Samples from a single year of the survey will only be provided in emergency situations (outbreaks). Research projects must use two-year cycles or multiple two year cycles for their research (i.e. 1999-2000, 2001-2002 etc.) In order to assure the representative nature of NHANES at least a \1/3\ sample of a two year cycle must be requested for an individual proposal. For details of the sampling design, see the Analytic Guidelines at: https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx. Starting in 1999, the consent form informed participants that they would not receive results from any future laboratory analysis that may be conducted on their samples. Therefore, only research proposals with laboratory test results that do not have clinical significance to the survey participant will be accepted. Clinical significance of a laboratory test will be judged by the technical panel reviewing proposals, and the researcher should address this in the research proposal. A laboratory analyte is considered clinically significant to the survey participant if the following criteria are met: The findings have significant implications for the participant's health, a course of action is readily available to treat the associated health concern, and laboratory tests are performed by a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory and therefore deemed valid. Serum, plasma, and urine samples are currently available from NHANES III (conducted from 1988-1994) and from NHANES 1999-2016 (Table A). Serum, plasma, and urine samples are stored in two biorepositories. Surplus samples that were initially used for laboratory assays included in the surveys, were stored at -70 [deg]C and have been through at least two freeze-thaw cycles. They are stored at a commercial biorepository under contract to NCHS. In addition, serum, plasma, and urine samples were also stored immediately after collection at -80 [deg]C or below in vapor-phase liquid nitrogen. These samples have not undergone a freeze-thaw cycle and are considered pristine samples. The CDC and Agency for Toxic Substances and Disease Registry (ATSDR) Sample Packaging and Handling Repository (CASPIR) is the long-term repository for the pristine NHANES serum, plasma, and urine samples. NCHS is making both of these collections available for research proposals. Proposals that request pristine samples stored at CASPIR should justify the use of the unthawed samples. Please see the NHANES Biospecimen Program series report for details about collection and storage of serum, plasma, and urine samples http://www.cdc.gov/nchs/data/series/sr_02/sr02_170.pdf. Table A--Overview of Biospecimens by Survey Year, NHANES III (1988-1994) and NHANES 1999-2014 ---------------------------------------------------------------------------------------------------------------- Sample Type ----------------------------------------------------------------- NHANES Cycle Pristine \1\ Surplus \2\ ----------------------------------------------------------------- Sera Plasma Urine Sera Plasma Urine ---------------------------------------------------------------------------------------------------------------- III (1988-1994)............................... X ......... ......... X ......... ......... 1999-2000..................................... X X X X X X 2001-2002..................................... X X X X X X 2003-2004..................................... X X X X ......... ......... [[Page 58207]] 2005-2006..................................... X X X X ......... ......... 2007-2008..................................... X X X X ......... ......... 2009-2010..................................... X X X X ......... ......... 2011-2012..................................... X ......... X X ......... ......... 2013-2014..................................... X ......... X X ......... ......... 2015-2016..................................... X ......... X X ......... ......... ---------------------------------------------------------------------------------------------------------------- \1\ Samples immediately frozen for storage, did not undergo laboratory testing. \2\ Samples were surplus after laboratories had completed testing. Proposal Evaluation All proposals for use of NHANES samples will be evaluated by a Technical Panel for scientific merit, public health significance, and lack of clinical significance to the participant; by the NCHS Confidentiality Officer for disclosure risk; and by the NCHS Human Subjects Officer and the ERB for any potential human subjects concerns. The NCHS Ethics Review Board (ERB) will review the proposal even if the investigator has received approval by their institutional review panel. The Technical Panel consists of NHANES staff: Two physicians, one statistician and two laboratory experts, other experts from inside or outside the Federal Government are added as needed. The Technical Panel will evaluate the proposal for the scientific, technical and medical significance of the research, the appropriateness and adequacy of the research design, and the methodology proposed to reach the research goals. See `Criteria for Technical Evaluation of Proposals' below. The proposal should outline how the results from the laboratory analysis will be used. Because NHANES is a complex, multistage probability sample of the U.S. population, the appropriateness of the NHANES sample to address the goals of the proposal will be an important aspect of scientific merit. The survey oversamples the two largest race/ethnic minority groups, non-Hispanic blacks and Mexican Americans (and all Hispanics since 2007-08), and, since 2011-2012, Asians. Sampling weights are therefore used to make national estimates of frequencies. The use of weights, sampling frame and methods of assessment of variables included in the data are likely to affect the proposed research. For this reason proposers are required to request at least a \1/3\ sample of a NHANES cycle to maintain the representative nature of the survey. The Technical Panel will also review the data analysis plan and evaluate whether the proposal is an appropriate use of the NHANES samples. The investigators should justify why they need a national probability sample for their research. The Technical Panel will assure that the proposed project does not go beyond either the general purpose for collecting the samples in the survey, or of the specific stated goals of the proposal. Investigators are encouraged to review the NHANES data, survey documents, manuals and questionnaires at: http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm or for NHANES III: https://wwwn.cdc.gov/nchs/nhanes/nhanes3/datafiles.aspx Procedures for Proposals All investigators (including CDC investigators) must submit a proposal for use of NHANES serum, plasma, or urine samples. Proposals are limited to a maximum of 10 single-spaced typed pages, excluding figures and tables, using at least a size 10 font 10cpi. The cover of the proposal should include the name, address, and phone number and Email address of the principal investigator (PI) and the name of the institution where the laboratory analysis will be done. All proposals should be Emailed to [email protected]v. Proposals must include a cover page with the title of the proposal and the name, address, phone number and Email address of all investigators. Proposals from CDC investigators must also include investigators scientific ethics verification number. The following criteria will be used for technical evaluation of proposals: Proposals should include the following information: (1) Specific Aims: List the broad objectives; describe concisely and realistically what the research is intended to accomplish, and state the specific hypotheses to be tested. NHANES is designed to provide prevalence estimates of diseases or conditions that are expected to affect at least 5-10 percent of the population. Research proposals that expect much lower prevalence estimates need to provide more detail on why samples from NHANES are needed for the project and provide details on how these data will be analyzed. (2) Background and Public Health Significance: Describe the public health significance, scientific merit, and practical utility of the assay. Briefly describe in 1-2 pages the background of the proposal, identifying gaps in knowledge that the project is intended to fill. State concisely the importance of the research in terms of the broad, long-term objectives and public health relevance including a discussion of how the results will affect public health policy or further scientific knowledge. The proposal should justify the need for samples that are representative of the U.S. population. The proposer should convey how the results will be used and the relationship of the results to the data already collected in NHANES. The analyses should be consistent with the NHANES mission and the health status variables. (3) Research Design and Methods: Describe the research design, analytic plan, and the procedures to be used. A detailed description of laboratory methods including validity and reliability must be included with references. The volume of sample and number of samples requested must be specified. Adequate methods for handling and storage of samples must also be addressed. The laboratory must demonstrate expertise in the proposed laboratory test including the capability for handling the workload requested in the proposal. The proposal should also include a justification for determination of sample size or a power calculation. If [[Page 58208]] the researcher is requesting a sub-sample of samples, a detailed description and justification, must be given. The researcher must describe how this sub-sample will be re-weighted to provide national estimates. The program will evaluate the Investigator's submitted proposal study design and analysis plan to determine whether the project is consistent with the design of the NHANES survey. In general, resulting data will be released in the public domain. Released data from sub- samples may be less useful to the research community, so such requests will receive a lower priority for the samples. (4) Clinical Significance of Results: Address the clinical significance to the survey participant of the proposed laboratory test. Since the consent document for sample storage and future studies states that individual results will not be provided to the participant, the investigator must address whether there is definitive evidence that the proposed test results have health implications to the participants and whether knowledge of results would provide grounds for medical intervention (even if many years have passed since the participant was in the survey and the sample collected). Any test with results that are clinically significant, and would require reporting to the participant, is not appropriate for testing on the stored serum, plasma, or urine samples; laboratory testing that is clinically significant should be considered for inclusion in a concurrent NHANES survey. (5) Qualification: Provide a brief description of the Principal Investigator's expertise in the proposed area, including publications in this area within the last three years. A representative sample of earlier publications may be listed as long as this section does not exceed two pages. (6) Period of Performance: Specify the project time period. Substantial progress must be made in the first year that samples have been obtained, and the project should be completed within a reasonable time period. Please discuss the approximate time the investigator expects this project will take to complete the project. At the end of the project period, any unused samples must be returned to the NHANES Specimen Repository or discarded. The NCHS Project Officer must be consulted about the disposition of the samples. (7) Funding: The source and status of the funding to perform the requested laboratory analysis should be included. Investigators will be responsible for the cost of processing and shipping the samples. The cost per sample is $13.00. The basis for the cost structure is in the last section of this document. Reimbursement for the samples will be collected before the samples are released. Submission of Proposals Proposals can be submitted in MS Word format by Email to: Dr. Geraldine McQuillan (see FOR FURTHER INFORMATION CONTACT). Project TimeframesSubmitting Proposals: Can be submitted on an ongoing basis Scientific Review Date: Within two months of proposal submission Institutional Review Date: Within one month of final proposal acceptance Anticipated distribution of samples: One month after ERB approval Approved Proposals Approved projects will be provided samples after receipt of a signed Materials Transfer Agreement (MTA) and a check (written to The Centers for Disease Control and Prevention) for the cost of the samples or for Federal Government proposals a signed Interagency Agreement (IAA). All laboratory results obtained from the samples must be sent back to NCHS to be linked to the variables requested by the investigator that are needed to perform a quality control review of the data under a signed Data Sharing Agreement or a Designated Agent Agreement. This review must take place within 60 days of the return of the data to NCHS so these data may be released to the public. All files will also undergo disclosure review at NCHS before release. Agency Agreement A formal signed agreement in the form of a MTA or an IAA with investigators who have projects approved will be completed before the release of the samples. This agreement will contain the conditions for use of the samples as stated in this document and as agreed upon by the investigators and CDC. Continuations A brief progress report will be submitted annually. This will be the basis for the NCHS ERB continuation reports that are required annually. After 5 years of annual continuations, if there is need for continued use of samples to complete the protocol study, a new protocol is required. Disposition of Results and Samples No samples provided can be used for any purpose other than those specifically requested in the proposal and approved by the Technical Panel and the NCHS ERB. No samples can be shared with others, including other investigators, unless specified in the proposal and so approved. Any unused samples must be returned to the NHANES Serum, Plasma and Urine Repository or disposed of, after NHANES approval, upon completion of the approved project. These results, once returned to NCHS, will be part of the public domain. The proposer will have 60 days for quality control review of the data before public release. Cost Schedule for Providing NHANES Samples There is a nominal processing fee of $13.00 for each sample received from the NHANES Serum, Plasma and Urine Repository. If the investigator requests to use the samples for another project after the completion of the initial project, the cost will be $5.00 per sample to handle the processing of the data and management of the proposal process. The costs include the collection, storage, and processing of the samples along with the review of proposals and the preparation of the data files. The costs listed are for the recurring laboratory materials to dispense and prepare the samples during collection and for shipping; the computer software needed for the preparation of the data files and for the release of the data along with documentation on the NHANES Web page. See: https://www.cdc.gov/nchs/nhanes/about_nhanes.htm. Labor costs are based on a proposal administrator and computer programmers at NCHS to prepare the data files. The storage and pulling the samples from the freezer fees include the costs for the NHANES repository. Fee Schedule for NHANES Biologic Samples ------------------------------------------------------------------------ Cost factors Cost per vial ------------------------------------------------------------------------ Material and Equipment.................................. $2.85 Processing the samples (Receiving, handling and 2.15 shipping).............................................. Administrative, management of the proposal process...... 1.50 Inventory management.................................... 1.50 Preparation of data files............................... 3.50 --------------- Subtotal............................................ 11.50 CDC Support (5%)........................................ 0.58 --------------- Subtotal............................................ 12.08 NCHS Support (7.50%).................................... 0.91 --------------- Total........................................... 13.00 * ------------------------------------------------------------------------ Total is rounded up from $12.99 [[Page 58209]] Dated: December 5, 2017. Sandra Cashman, Executive Secretary, Centers for Disease Control and Prevention. [FR Doc. 2017-26591 Filed 12-8-17; 8:45 am] BILLING CODE 4163-18-P
![58206 Federal Register / Vol. 82, No. 236 / Monday, December 11, 2017 / Notices
DEPARTMENT OF HEALTH AND (1) To estimate the number and percent laboratory analysis that may be
HUMAN SERVICES of persons in the U.S. population and conducted on their samples. Therefore,
designated subgroups with selected only research proposals with laboratory
Centers for Disease Control and diseases and risk factors; (2) to monitor test results that do not have clinical
Prevention trends in the prevalence, awareness, significance to the survey participant
[Docket No. CDC–2017–0117] treatment and control of selected will be accepted. Clinical significance of
diseases; (3) to monitor trends in risk a laboratory test will be judged by the
National Health and Nutrition behaviors and environmental exposures; technical panel reviewing proposals,
Examination Survey (NHANES) Stored (4) to analyze risk factors for selected and the researcher should address this
Biologic Samples; Proposed Cost diseases; (5) to study the relationship in the research proposal. A laboratory
Schedule and Guidelines for Proposals between diet, nutrition and health; (6) to analyte is considered clinically
to Use Serum, Plasma, and Urine explore emerging public health issues significant to the survey participant if
Samples and new technologies; and (7) to the following criteria are met: The
establish and maintain a national findings have significant implications
AGENCY: Centers for Disease Control and probability sample of baseline
Prevention (CDC), Department of Health for the participant’s health, a course of
information on health and nutrition action is readily available to treat the
and Human Services (HHS). status. associated health concern, and
ACTION: Notice. Samples are available from NHANES laboratory tests are performed by a
SUMMARY: The Centers for Disease III and the continuous NHANES that Clinical Laboratory Improvement
Control and Prevention (CDC) in the started in 1999. Approximately 30,000 Amendments (CLIA)-certified laboratory
Department of Health and Human individuals were examined in NHANES and therefore deemed valid.
Services (HHS) announces the III, which began in the fall of 1988, and
Serum, plasma, and urine samples are
availability of stored sera, plasma, and ended in the fall of 1994. Researchers
can analyze data from this survey in two currently available from NHANES III
urine samples obtained from (conducted from 1988–1994) and from
participants in the National Health and phases. Phase 1 was conducted from
October 1988 to October 1991 and Phase NHANES 1999–2016 (Table A).
Nutrition Examination Survey
(NHANES) for use and the fee schedule 2 began October 1991 and ended Serum, plasma, and urine samples are
for such use. The National Health and October 1994. Though participants stored in two biorepositories. Surplus
Nutrition Examination Survey consented to storing samples of their samples that were initially used for
(NHANES) is one of a series of health- blood and urine for future testing, only laboratory assays included in the
related surveys conducted by CDC’s research proposals with test results that surveys, were stored at ¥70 °C and have
National Center for Health Statistics are judged not to have clinical been through at least two freeze-thaw
(NCHS). significance for participants will be cycles. They are stored at a commercial
accepted. See: http://www.cdc.gov/ biorepository under contract to NCHS.
DATES: The stored NHANES biologic nchs/nhanes/nhanes3.htm, for more In addition, serum, plasma, and urine
samples are available December 11, information on NHANES III. samples were also stored immediately
2017. The fee structure for these Beginning in 1999, NHANES became after collection at ¥80 °C or below in
samples is effective December 11, 2017. a continuous, annual survey with vapor-phase liquid nitrogen. These
FOR FURTHER INFORMATION CONTACT: Dr. examination of approximately 5,000 samples have not undergone a freeze-
Geraldine McQuillan, National Center individuals a year and data release thaw cycle and are considered pristine
for Health Statistics, Centers for Disease every two years. Samples from a single samples. The CDC and Agency for Toxic
Control and Prevention, 3311 Toledo year of the survey will only be provided Substances and Disease Registry
Road, Hyattsville, MD 20782. in emergency situations (outbreaks). (ATSDR) Sample Packaging and
Telephone: 301–458–4371; Fax: 301– Research projects must use two-year Handling Repository (CASPIR) is the
458–4029; Email: Serumplasmaurine@ cycles or multiple two year cycles for long-term repository for the pristine
cdc.gov their research (i.e. 1999–2000, 2001– NHANES serum, plasma, and urine
Authority: Sections 301,306 and 308 of the 2002 etc.) In order to assure the samples. NCHS is making both of these
Public Health Service Act (42 U.S.C. representative nature of NHANES at collections available for research
241,242k and 242M). least a 1⁄3 sample of a two year cycle proposals. Proposals that request
SUPPLEMENTARY INFORMATION: NHANES must be requested for an individual pristine samples stored at CASPIR
is a program of periodic surveys proposal. For details of the sampling should justify the use of the unthawed
conducted by NCHS. Examination design, see the Analytic Guidelines at: samples. Please see the NHANES
surveys conducted since 1960 by NCHS https://wwwn.cdc.gov/nchs/nhanes/ Biospecimen Program series report for
have provided national estimates of the analyticguidelines.aspx. details about collection and storage of
health and nutritional status of the U.S. Starting in 1999, the consent form serum, plasma, and urine samples
civilian non-institutionalized informed participants that they would http://www.cdc.gov/nchs/data/series/sr_
population. The goals of NHANES are: not receive results from any future 02/sr02_170.pdf.
TABLE A—OVERVIEW OF BIOSPECIMENS BY SURVEY YEAR, NHANES III (1988–1994) AND NHANES 1999–2014
Sample Type
daltland on DSKBBV9HB2PROD with NOTICES
NHANES Cycle Pristine 1 Surplus 2
Sera Plasma Urine Sera Plasma Urine
III (1988–1994) ..................................................................................................... X .............. .............. X .............. ..............
1999–2000 ........................................................................................................... X X X X X X
2001–2002 ........................................................................................................... X X X X X X
2003–2004 ........................................................................................................... X X X X .............. ..............
VerDate Sep<11>2014 17:54 Dec 08, 2017 Jkt 244001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\11DEN1.SGM 11DEN1](https://thefederalregister.org/doc/82_FR_58442/page/1.svg)
![Federal Register / Vol. 82, No. 236 / Monday, December 11, 2017 / Notices 58209
Dated: December 5, 2017. proposed collection(s) summarized in enrollment. Form Number: CMS–10142
Sandra Cashman, this notice, you may make your request (OMB control number: 0938–0944);
Executive Secretary, Centers for Disease using one of following: Frequency: Yearly; Affected Public:
Control and Prevention. 1. Access CMS’ Web site address at Private sector (Business or other for-
[FR Doc. 2017–26591 Filed 12–8–17; 8:45 am] Web site address at https:// profits and Not-for-profit institutions);
BILLING CODE 4163–18–P www.cms.gov/Regulations-and- Number of Respondents: 555; Total
Guidance/Legislation/ Annual Responses: 4,995; Total Annual
PaperworkReductionActof1995/PRA- Hours: 149,850. (For policy questions
DEPARTMENT OF HEALTH AND Listing.html. regarding this collection contact Rachel
HUMAN SERVICES 2. Email your request, including your Shevland at 410–786–3026.)
address, phone number, OMB number, Dated: December 6, 2017.
Centers for Medicare & Medicaid and CMS document identifier, to
Services William N. Parham, III,
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at Director, Paperwork Reduction Staff, Office
[Document Identifier: CMS–10142] of Strategic Operations and Regulatory
(410) 786–1326. Affairs.
Agency Information Collection FOR FURTHER INFORMATION CONTACT: [FR Doc. 2017–26604 Filed 12–8–17; 8:45 am]
Activities: Submission for OMB William Parham at (410) 786–4669. BILLING CODE 4120–01–P
Review; Comment Request SUPPLEMENTARY INFORMATION: Under the
AGENCY: Centers for Medicare & Paperwork Reduction Act of 1995 (PRA)
Medicaid Services, Department of (44 U.S.C. 3501–3520), federal agencies DEPARTMENT OF HEALTH AND
Health and Human Services. must obtain approval from the Office of HUMAN SERVICES
ACTION: Notice. Management and Budget (OMB) for each
collection of information they conduct Centers for Medicare & Medicaid
SUMMARY: The Centers for Medicare & or sponsor. The term ‘‘collection of Services
Medicaid Services (CMS) is announcing information’’ is defined in 44 U.S.C. [Document Identifier: CMS–10529]
an opportunity for the public to 3502(3) and 5 CFR 1320.3(c) and
comment on CMS’ intention to collect includes agency requests or Agency Information Collection
information from the public. Under the requirements that members of the public Activities: Submission for OMB
Paperwork Reduction Act of 1995 submit reports, keep records, or provide Review; Comment Request
(PRA), federal agencies are required to information to a third party. Section
publish notice in the Federal Register 3506(c)(2)(A) of the PRA (44 U.S.C. AGENCY: Centers for Medicare &
concerning each proposed collection of 3506(c)(2)(A)) requires federal agencies Medicaid Services, HHS.
information, including each proposed to publish a 30-day notice in the ACTION: Notice.
extension or reinstatement of an existing Federal Register concerning each
collection of information, and to allow SUMMARY: The Centers for Medicare &
proposed collection of information,
a second opportunity for public Medicaid Services (CMS) is announcing
including each proposed extension or
comment on the notice. Interested an opportunity for the public to
reinstatement of an existing collection
persons are invited to send comments comment on CMS’ intention to collect
of information, before submitting the
regarding the burden estimate or any information from the public. Under the
collection to OMB for approval. To
other aspect of this collection of Paperwork Reduction Act of 1995
comply with this requirement, CMS is
information, including the necessity and (PRA), federal agencies are required to
publishing this notice that summarizes
utility of the proposed information publish notice in the Federal Register
the following proposed collection(s) of
collection for the proper performance of concerning each proposed collection of
information for public comment:
the agency’s functions, the accuracy of information, including each proposed
1. Type of Information Collection
the estimated burden, ways to enhance extension or reinstatement of an existing
Request: Revision of a currently
the quality, utility, and clarity of the collection of information, and to allow
approved collection; Title of
information to be collected; and the use a second opportunity for public
Information Collection: Bid Pricing Tool
of automated collection techniques or comment on the notice. Interested
(BPT) for Medicare Advantage (MA)
other forms of information technology to persons are invited to send comments
Plans and Prescription Drug Plans
minimize the information collection regarding the burden estimate or any
(PDP); Use: We require that Medicare
burden. other aspect of this collection of
Advantage organizations and
information, including the necessity and
DATES: Comments on the collection(s) of Prescription Drug Plans complete the
utility of the proposed information
information must be received by the BPT as part of the annual bidding
collection for the proper performance of
OMB desk officer by January 10, 2018. process. During this process,
the agency’s functions, the accuracy of
ADDRESSES: When commenting on the organizations prepare their proposed
the estimated burden, ways to enhance
proposed information collections, actuarial bid pricing for the upcoming
the quality, utility, and clarity of the
please reference the document identifier contract year and submit them to us for
information to be collected; and the use
or OMB control number. To be assured review and approval. The purpose of the
of automated collection techniques or
consideration, comments and BPT is to collect the actuarial pricing
other forms of information technology to
recommendations must be received by information for each plan. The BPT
minimize the information collection
the OMB desk officer via one of the calculates the plan’s bid, enrollee
daltland on DSKBBV9HB2PROD with NOTICES
burden.
following transmissions: OMB, Office of premiums, and payment rates. We
Information and Regulatory Affairs, publish beneficiary premium DATES: Comments on the collection(s) of
Attention: CMS Desk Officer, Fax information using a variety of formats information must be received by the
Number: (202) 395–5806 OR Email: (www.medicare.gov, the Medicare & You OMB desk officer by January 10, 2018.
OIRA_submission@omb.eop.gov. handbook, Summary of Benefits ADDRESSES: When commenting on the
To obtain copies of a supporting marketing information) for the purpose proposed information collections,
statement and any related forms for the of beneficiary education and please reference the document identifier
VerDate Sep<11>2014 17:54 Dec 08, 2017 Jkt 244001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\11DEN1.SGM 11DEN1](https://thefederalregister.org/doc/82_FR_58442/page/4.svg)
Document Created: 2017-12-09 01:49:58
Document Modified: 2017-12-09 01:49:58
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | The stored NHANES biologic samples are available December 11, 2017. The fee structure for these samples is effective December 11, 2017. | |
| Contact | Dr. Geraldine McQuillan, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Hyattsville, MD 20782. Telephone: 301- 458-4371; Fax: 301-458-4029; Email: [email protected] | |
| FR Citation | 82 FR 58206 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR